ERK2/p38α MAPK-IN-1 | MedChemExpress (MCE)
ERK2/p38α MAPK-IN-1 (Compound 1, In silico Hit-2) is a potent and selective ERK2 and p38α MAPK inhibitor, with an IC50 of 82 μM for ERK2. ERK2/p38α MAPK-IN-1 binds to the allosteric site of ERK2 and p38α MAPK in distinct manners. ERK2/p38α MAPK-IN-1 can be used for the research of type 2 diabetes[1].
| Trivial name | ERK2/p38α MAPK-IN-1 |
| Catalog Number | HY-161462 |
| Research Area | Cancer |
| CAS# | 1016427-72-7 |
| Purity | ≥98.0% |
| SMILES | COC1=C(OC)C=C(N=C(NC(C2=CSC(COC3=CC=C(F)C=C3)=N2)=O)S4)C4=C1 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/erk2-p38α-mapk-in-1.html |